Abstract
The Hepatocellular Carcinoma (HCC) displays a high incidence and mortality worldwide, also featuring a poor prognosis. Many patients in advanced disease stages are submitted to low response antitumoral therapies. Tumor microenvironment modulation is also neglected in current targeted therapies. A myriad of epidemiological studies indicate that coffee consumption reduced by 40% the HCC ris…